CD8A and acute myeloid leukemia: We observed that the majority of CD8+ T cells in the bone marrow of AML patients expressed Siglec-7, while circulating Siglec-7+ CD8+ T cells in AML patients were found at similar levels as compared to healthy donors (Figure 6F).